Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 23 results for "zydus cadilla"

Allergan settles Delzicol patent litigation with generic firms

Allergan (NYSE: AGN ) and Qualicaps Co. Ltd., have settled their patent infringement litigation with Zydus Pharmaceuticals and Cadilla Healthcare Limited related to U.S. Patent No. 6,649,180 covering ulcerative colitis med DELZICOL (mesalamine). The ... Seeking Alpha, 1 week ago

Shire Reports Q3 2016 Results with Record Revenues and Reiterates Full Year Non GAAP Guidance

/PRNewswire/ -- Very strong U.S. launch for XIIDRA; marks outstanding entry into ophthalmics Baxalta integration progressing well with synergy initiatives ahead of plan Shire plc (Shire) (LSE: SHP, NASDAQ: SHPG) announces unaudited results for ...
 TickerTech.com1 month ago SHIRE PLC : - 3rd Quarter Results  4 Traders1 month ago SHIRE PLC - 3rd Quarter Results  UKCityMedia1 month ago Shire plc 3rd Quarter Results  ADVFN UK1 month ago

Oral Proteins and Peptides Market - Emerging Trends and New Technologies Research 2013 - 2019

The International Diabetes Federation states that there will be 592 million diabetics by the end of 2035 up from 382 million in 2013, which has created a significant need for advanced therapies. In addition to this shocking statistic, the growth in ...
 MyNewsDesk1 month ago Global Oral Proteins and Peptides Market 2016: Industry Review, Research, Statistics, and Growth to 2021  Digital Journal1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less